measuregroup/AID408262

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID123097261_AID408262_PMID18429610_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103620454_AID408262_PMID18429610_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103620516_AID408262_PMID18429610_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103620455_AID408262_PMID18429610_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103620517_AID408262_PMID18429610_VALUE4
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/cell/CELLID25
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Antiproliferative activity against human Caco-2 cells assessed as cell proliferation at 50 nM after 78 hrs relative to control
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103620517 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103620516 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID123097261 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103620454 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103620455
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID408262

Total number of triples: 15.